BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 26561022)

  • 1. Analysing extremely small sized ratio datasets.
    Ricchiuto P; Sng JC; Goh WW
    Int J Bioinform Res Appl; 2015; 11(3):268-80. PubMed ID: 26561022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarker discovery using dry-lab technologies and high-throughput screening.
    Chang HT
    Biomark Med; 2016 Jun; 10(6):559-61. PubMed ID: 27278686
    [No Abstract]   [Full Text] [Related]  

  • 3. Avoiding a replication crisis in deep-learning-based bioimage analysis.
    Laine RF; Arganda-Carreras I; Henriques R; Jacquemet G
    Nat Methods; 2021 Oct; 18(10):1136-1144. PubMed ID: 34608322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LIPID MAPS: Serving the next generation of lipid researchers with tools, resources, data, and training.
    O'Donnell VB; Dennis EA; Wakelam MJO; Subramaniam S
    Sci Signal; 2019 Jan; 12(563):. PubMed ID: 30622195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protocol for Standardizing High-to-Moderate Abundance Protein Biomarker Assessments Through an MRM-with-Standard-Peptides Quantitative Approach.
    Percy AJ; Yang J; Chambers AG; Mohammed Y; Miliotis T; Borchers CH
    Adv Exp Med Biol; 2016; 919():515-530. PubMed ID: 27975233
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computational proteomics: designing a comprehensive analytical strategy.
    Goh WW; Wong L
    Drug Discov Today; 2014 Mar; 19(3):266-74. PubMed ID: 23872277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A plea for "omics" research in complex diseases such as multiple sclerosis--a change of mind is needed.
    Martin R; Leppert D
    J Neurol Sci; 2004 Jul; 222(1-2):3-5. PubMed ID: 15240188
    [No Abstract]   [Full Text] [Related]  

  • 8. A quantum leap in the reproducibility, precision, and sensitivity of gene expression profile analysis even when sample size is extremely small.
    Lim K; Li Z; Choi KP; Wong L
    J Bioinform Comput Biol; 2015 Aug; 13(4):1550018. PubMed ID: 26166210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topics in Study Design and Analysis for Multistage Clinical Proteomics Studies.
    Zeng IS
    Methods Mol Biol; 2016; 1362():29-61. PubMed ID: 26519168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omics-bioinformatics in the context of clinical data.
    Mayer G; Heinze G; Mischak H; Hellemons ME; Heerspink HJ; Bakker SJ; de Zeeuw D; Haiduk M; Rossing P; Oberbauer R
    Methods Mol Biol; 2011; 719():479-97. PubMed ID: 21370098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advancing Clinical Proteomics via Analysis Based on Biological Complexes: A Tale of Five Paradigms.
    Goh WW; Wong L
    J Proteome Res; 2016 Sep; 15(9):3167-79. PubMed ID: 27454466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-depth analysis of protein inference algorithms using multiple search engines and well-defined metrics.
    Audain E; Uszkoreit J; Sachsenberg T; Pfeuffer J; Liang X; Hermjakob H; Sanchez A; Eisenacher M; Reinert K; Tabb DL; Kohlbacher O; Perez-Riverol Y
    J Proteomics; 2017 Jan; 150():170-182. PubMed ID: 27498275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional genomics and proteomics in the clinical neurosciences: data mining and bioinformatics.
    Phan JH; Quo CF; Wang MD
    Prog Brain Res; 2006; 158():83-108. PubMed ID: 17027692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiscale network-based approaches in bioinformatics and biomedicine.
    Zheng HJ; Hu XT
    Methods; 2020 Feb; 173():1-2. PubMed ID: 31926262
    [No Abstract]   [Full Text] [Related]  

  • 15. The appropriateness of Bland-Altman's approximate confidence intervals for limits of agreement.
    Shieh G
    BMC Med Res Methodol; 2018 May; 18(1):45. PubMed ID: 29788915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applications and limitations of in silico models in drug discovery.
    Sacan A; Ekins S; Kortagere S
    Methods Mol Biol; 2012; 910():87-124. PubMed ID: 22821594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges and opportunities for oncology biomarker discovery.
    Deyati A; Younesi E; Hofmann-Apitius M; Novac N
    Drug Discov Today; 2013 Jul; 18(13-14):614-24. PubMed ID: 23280501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ten simple rules for reproducible computational research.
    Sandve GK; Nekrutenko A; Taylor J; Hovig E
    PLoS Comput Biol; 2013 Oct; 9(10):e1003285. PubMed ID: 24204232
    [No Abstract]   [Full Text] [Related]  

  • 19. Computational toxicology as implemented by the U.S. EPA: providing high throughput decision support tools for screening and assessing chemical exposure, hazard and risk.
    Kavlock R; Dix D
    J Toxicol Environ Health B Crit Rev; 2010 Feb; 13(2-4):197-217. PubMed ID: 20574897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigating subsumption in SNOMED CT: an exploration into large description logic-based biomedical terminologies.
    Bodenreider O; Smith B; Kumar A; Burgun A
    Artif Intell Med; 2007 Mar; 39(3):183-95. PubMed ID: 17241777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.